Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, operates within in research, early clinical stages and CMC biologics development from research to market. Supporting Servier’s commitment to improve patients health and the R&D strategy within oncology and immune-oncology - Symphogen’s strategic focus is to apply our streamlined and effective antibody platform and capabilities in the discovery and early development of highly differentiated antibodies. The aim is to develop novel compounds either as combination or as stand-alone therapies for difficult to treat cancers.
Company Details
- Employees
- 195
- Founded
- -
- Address
- Pederstrupvej 93, Ballerup,2750,denmark
- Phone
- 45 45 26 50 50
- in****@****gen.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- symphogen.com
- Keywords
- oncology, immune-evasive, AXL.
- HQ
- Ballerup
Symphogen Questions
Symphogen's helpline number is 45 45 26 50 50
Symphogen's website is symphogen.com
Symphogen's LinkedIn profile is https://www.linkedin.com/company/symphogen
Symphogen has
195 employees.
View email and phone details for 195
employees at Symphogen.
Symphogen's industry is
Biotechnology Research
Symphogen's top competitors are
Ascendis Pharma,
Genmab,
Adcendo,
Gubra,
Immudex,
Evaxion A/s,
Zealand Pharma,
Biosyntia,
Lundbeck,
Nordic Bioscience.
Symphogen's support email address is info@symphogen.com
Symphogen's categories are Biotechnology Research
Symphogen's founding year is 2000
